Effects of early albuterol (salbutamol) administration on the development of posttraumatic stress symptoms

Psychiatry Research

Volumn 185, Issue 1-2, 2011, Pages 296-298

  Kobayashi, Ihori ^a,b   Sledjeski, Eve ^c   Fallon, William ^d   Spoonster, Eileen ^d   Riccio, David ^a   Delahanty, Douglas ^a,e  

^a KENT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c ROWAN UNIVERSITY   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

^e NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

2 adrenergic receptor agonist; Motor vehicle accident; Pharmacologic intervention

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; EARLY INTERVENTION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RIB FRACTURE; SCORING SYSTEM; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ALBUTEROL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; YOUNG ADULT;

EID: 78650217492     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.10.016     Document Type: Article

References (13)

1. Baker S.P., O'Neill B., Haddon W.J., Long W.B. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 1974, 14:187-196.
2. Bellenir K. Asthma Sourcebook 2006, Omnigraphics, Detroit, MI. 2nd ed.
3. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Klauminzer G., Charney D.S., Keane T.M. A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1. Behav. Ther. 1990, 13:187-188.
4. Caccia S., Fong M.H. Kinetics and distribution of the β-adrenergic agonist salbutamol in rat brain. J. Pharm. Pharmacol. 1983, 36:200-202.
5. Elias P.C., Sagua D., Alvarez E.O. Chronic aerial exposure to glucorticoids or beta-agonists affects avoidance learning and exploratory motivation in rats. Behav. Brain Res. 2004, 149:95-105.
6. McAinsh J., Cruickshank J.M. Beta-blockers and central nervous system side effects. Pharmacol. Ther. 1990, 46:163-197.
7. McAllister D.E., McAllister W.R. Fear theory and aversively motivated behavior: some controversial issues. Fear, Avoidance, and Phobias: A Fundamental Analysis 1991, 135-163. Lawrence Erlbaum Associates, Hillsdale, NJ. M.R. Denny (Ed.).
8. McGaugh J.L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu. Rev. Neurosci. 1989, 12:255-287.
9. Pitman R.K., Delahanty D.L. Conceptually driven pharmacologic approaches to acute trauma. CNS Spectrums 2005, 10:99-106.
10. Pitman R.K., Sanders K.M., Zusman R.M., Healy A.R., Cheema F., Lasko N.B., Cahill L., Orr S.P. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry 2002, 51:189-192.
11. Schelling G., Briegel J., Roozendaal B., Stoll C., Rothenhaeusler Hans-Bernd The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol. Psychiatry 2001, 50:978-985.
12. Teasdale G., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974, 2:81-84.
13. Weiss D.S. The impact of event scale-revised. Assessing Psychological Trauma and PTSD 2004, 168-189. Guilford Press, New York. 2nd ed. J.P. Wilson, T.M. Keane (Eds.).